Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

It also fixed the price of a popular drug combination used to treat type 2 diabetes mellitus—dapagliflozin, teneligliptin, and metformin—at ₹11.60 per tablet, and the price of another anti ...

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...

Sotagliflozin, a newly FDA-approved medication for treating type 2 diabetes and kidney disease with added cardiovascular risks, has been shown to greatly lower the risk of heart attacks and ...

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 ...

and drug stability of current therapies remain limited. Plant-based treatments, which have long been used in traditional medicine, are now being investigated for anti-diabetic properties.

Background: Some anti-diabetic drugs have been proved to be a tumor suppressor or activator. The associations of three relatively new classes of anti-diabetic medications–glucagon-like peptide-1 ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes ... of popular anti-obesity drugs, so long as the ...

But before we wade into the risks and study data, let’s get on the same page about the list of active ingredients that could help reduce the number you see on the scale. Diabetes drugs generally ...